Cleared Traditional

3880 MRI Patient Monitoring System (K180903) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180903 · Iradimed Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
357d
Days
Class 2
Risk

K180903 is an FDA 510(k) clearance for the 3880 MRI Patient Monitoring System. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Iradimed Corporation (Winter Springs, US). The FDA issued a Cleared decision on March 29, 2019 after a review of 357 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Iradimed Corporation devices

Submission Details

510(k) Number K180903 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 2018
Decision Date March 29, 2019
Days to Decision 357 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
232d slower than avg
Panel avg: 125d · This submission: 357d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 111
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K180903.
SmartLinx Vitals Plus Patient Monitoring System
K183638 · Capsule Technologie · Apr 2019
Connect App for iHealth Next, iHealth React Native SDK, iHealth React Native Library SDK, iHealth Library SDK, iHealth Native SDK
K181541 · Andon Health Co, Ltd. · Apr 2019
Patient Monitor
K181919 · Guangdong Biolight Meditech Co., Ltd. · Apr 2019
Accutorr 7/VS-900/VS-900c Vital Signs Monitor
K182821 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Mar 2019
Handheld VitalSigns Monitoring System
K172965 · Visiomed Technology Co.,Ltd · Dec 2018
3880 MRI Patient Monitoring System
K182900 · Iradimed Corporation · Dec 2018